SCHEMBL24696358

SCHEMBL24696358

CCOC(=O)c1cc2nc(CCC3CCCC3)cc(O)n2n1

nearest known ligand 0.47

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.43
▸ HPGD P15428 4/20 0.43
▸ ALDH1A1 P00352 3/20 0.43
▸ POLB P06746 2/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ FAAH O00519 3/20 0.37
▸ LMNA P02545 1/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ NPC1 O15118 2/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ RXFP1 Q9HBX9 1/20 0.35
▸ CSNK1D P48730 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ ADORA3 P0DMS8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24696353 0.99 KDM4E (0.42) KDM4EHPGDALDH1A1POLBSMN1; SMN2
SCHEMBL24696347 0.89 KDM4E (0.40) KDM4EHPGDALDH1A1POLBSMN1; SMN2
SCHEMBL24696371 0.88 KDM4E (0.42) KDM4EHPGDALDH1A1POLBSMN1; SMN2
SCHEMBL24695972 0.88 SMN1; SMN2 (0.41) KDM4EHPGDALDH1A1POLBSMN1; SMN2
SCHEMBL24695628 0.88 SMN1; SMN2 (0.41) KDM4EHPGDALDH1A1POLBSMN1; SMN2
SCHEMBL24696376 0.88 KDM4E (0.41) KDM4EHPGDALDH1A1POLBSMN1; SMN2
SCHEMBL24695633 0.87 KDM4E (0.40) KDM4EHPGDALDH1A1POLBSMN1; SMN2
SCHEMBL24696352 0.87 KDM4E (0.41) KDM4EHPGDALDH1A1POLBSMN1; SMN2
SCHEMBL24696368 0.86 KDM4E (0.40) KDM4EHPGDALDH1A1POLBSMN1; SMN2
SCHEMBL24696355 0.86 KDM4E (0.40) KDM4EHPGDALDH1A1POLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022255408-A1 PYRAZOLO[1,5-A]PYRIMIDINE COMPOUND FOR THE TREATMENT OF DERMAL DISORDERS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2022-12-08 — — WO disclosed
Send feedback